Valuation: Mega Lifesciences

Market Cap 3.36TCr 101.41Cr 88Cr 82Cr 75Cr 142.3Cr 9.66TCr 144.16Cr 964.03Cr 378.33Cr 4.83TCr 380.75Cr 372.47Cr 16TCr P/E 2026 *
14.4x
P/E 2027 * 13.6x
Enterprise Value 2.9TCr 87Cr 76Cr 71Cr 65Cr 122.75Cr 8.33TCr 124.36Cr 831.59Cr 326.36Cr 4.16TCr 328.44Cr 321.3Cr 14TCr EV / Sales 2026 *
1.94x
EV / Sales 2027 * 1.84x
Free-Float
38.61%
Yield 2026 *
4.58%
Yield 2027 * 4.9%
1 week+2.67%
Current month+1.32%
1 month+1.99%
3 months+8.45%
6 months+1.99%
Current year+14.93%
1 week 37.5
Extreme 37.5
39.75
1 month 36.5
Extreme 36.5
39.75
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 17.4
Extreme 17.4
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 62 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Date Insider Type Main position Quantity % Market Cap.
29/04/25 Buy

Chief Executive Officer

1,00,000 0.0115%
28/04/25 Buy

Chief Executive Officer

50,000 0.0057%
28/04/25 Buy

Chief Executive Officer

1,50,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.67%+26.23%0.00% 101.44Cr
+1.89%+3.20%+59.70%+162.50% 1,04300Cr
-0.24%+0.45%+50.64%+48.46% 62TCr
-0.95%-5.26%+24.23%+62.22% 44TCr
0.00%+0.83%+42.80%+37.60% 36TCr
+0.58%-3.51%+31.12%+40.54% 29TCr
-1.55%-9.78%+5.61%+8.62% 25TCr
-0.73%+4.44%+42.22%+60.06% 22TCr
-0.24%-13.15%-4.02%-44.69% 20TCr
-0.68%-0.32%+18.66%+62.22% 16TCr
Average -0.21%-3.30%+29.72%+43.75% 35.9TCr
Weighted average by Cap. +0.23%-3.79%+39.50%+74.84%

Financials

2026 *2027 *
Net sales 1.49TCr 45Cr 39Cr 37Cr 33Cr 63Cr 4.29TCr 64Cr 428.35Cr 168.11Cr 2.14TCr 169.18Cr 165.5Cr 7.14TCr 1.57TCr 47Cr 41Cr 39Cr 35Cr 67Cr 4.51TCr 67Cr 450.58Cr 176.83Cr 2.26TCr 177.96Cr 174.09Cr 7.51TCr
Net income 233.16Cr 7.04Cr 6.11Cr 5.72Cr 5.24Cr 9.88Cr 670.99Cr 10Cr 67Cr 26Cr 335.25Cr 26Cr 26Cr 1.12TCr 247.23Cr 7.47Cr 6.48Cr 6.07Cr 5.55Cr 10Cr 711.5Cr 11Cr 71Cr 28Cr 355.49Cr 28Cr 27Cr 1.18TCr
Net Debt -461.15Cr -14Cr -12Cr -11Cr -10Cr -20Cr -1.33TCr -20Cr -132.44Cr -52Cr -663.06Cr -52Cr -51Cr -2.21TCr -475.96Cr -14Cr -12Cr -12Cr -11Cr -20Cr -1.37TCr -20Cr -136.69Cr -54Cr -684.36Cr -54Cr -53Cr -2.28TCr
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
06/26/06 THB 38.50 0.00% 7,96,791
05/26/05 THB 38.50 -0.65% 6,02,037
04/26/04 THB 38.75 -1.90% 15,62,624
03/26/03 THB 39.50 +3.95% 23,11,346
31/26/31 THB 38.00 +0.66% 4,62,251
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
38.50THB
Average target price
42.43THB
Spread / Average Target
+10.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock